Health Canada drug identification number

DIN 02255723 — RISPERDAL CONSTA 37.5 MG

RISPERDAL CONSTA is a kit; powder for suspension (sustained-release of Risperidone (Long-Acting Injection) marketed by JANSSEN INC. The full Risperidone (Long-Acting Injection) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02255723
Brand name
RISPERDAL CONSTA
Strength
37.5 MG
Dosage form
KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE
Route
INTRAMUSCULAR
Manufacturer
JANSSEN INC
Health Canada status
MARKETED
Drug class
Atypical (second-generation) antipsychotic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Risperidone (Long-Acting Injection) products

DINBrandStrengthFormManufacturerStatus
02544628 OKEDI 100 MG KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE LABORATORIOS FARMACEUTICOS ROVI, S.A. MARKETED
02544601 OKEDI 75 MG KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE LABORATORIOS FARMACEUTICOS ROVI, S.A. MARKETED
02298465 RISPERDAL CONSTA 12.5 MG KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE JANSSEN INC MARKETED
02255707 RISPERDAL CONSTA 25 MG KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE JANSSEN INC MARKETED
02255758 RISPERDAL CONSTA 50 MG KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE JANSSEN INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.